insights_auto
Why is GMAB up 3,78%?
Dive Deeperchevron_right
GMAB:CPH
Genmab A/S
2 445,00 DKK
arrow_upward
+3,78%(+89,00) 1D
9 ოქტ, 17:00:00 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
2 425,00 DKK
High
2 472,00 DKK
Low
2 400,00 DKK
Mkt. cap
146,84 მლრ.
Avg. vol.
125,50 ათ.
Volume
96,37 ათ.
52-wk high
2 603,00 DKK
52-wk low
1 512,00 DKK
Shares outstanding
62,41 მლნ.
No. of employees
3 ათ.
Open
2 425,00 DKK
High
2 472,00 DKK
Low
2 400,00 DKK
Mkt. cap
146,84 მლრ.
Avg. vol.
125,50 ათ.
Volume
96,37 ათ.
52-wk high
2 603,00 DKK
52-wk low
1 512,00 DKK
Shares outstanding
62,41 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Investing.com
·
2 დღის წინ
H.C. Wainwright raises Genmab stock price target on positive trial data
Yahoo Finance
·
3 დღის წინ
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
Fierce Pharma
·
3 დღის წინ
AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy
TradingView
·
3 დღის წინ
European shares gain as Genmab jumps, bond yields retreat
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S